How Does Japan Handle Audits For Combination Products With Both Drug And Device Components?

Japan handles audits for combination products through a coordinated approach involving the Pharmaceuticals and Medical Devices Agency (PMDA). The PMDA evaluates both drug and device components, ensuring compliance with regulatory standards. Manufacturers must submit comprehensive documentation, and audits focus on quality management systems, safety, and efficacy to ensure product integrity.

Leave a Reply

You must be logged in to post a comment.